Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Doctor Wise is an online medical AI platform for medical students and healthcare professionals, positioning itself around “evidence-based medical AI.” Unlike general-purpose chatbots, its product messaging emphasizes that answers are based on medical literature, clinical guidelines, and official sources, with reference links provided in every response. It is suitable for study, case discussions, drug lookups, and clinical reasoning support.
Its core features include medical Q&A, clinical case discussion, scientific article search and interpretation, drug label lookup, and generation of medical visuals such as charts, flowcharts, and mind maps. The platform supports paper searches by DOI, title, author, or PubMed link, and can incorporate literature content into AI analysis. For Brazilian users, a particularly valuable feature is its integration with official Anvisa drug labels, along with the option to set regulatory contexts such as Brazil, the EU, the US, or global. However, the website does not disclose the underlying model, provider, validation datasets, or real-world clinical evaluation data.
The free plan includes 20 questions per week, 5 messages per conversation, 7 days of history, and a 500-character limit per question. PLUS costs R$229.90 per year, about R$19.16/month, and includes 250 questions/month, unlimited conversations, and 90 days of history. PRO costs R$419.90 per year, about R$34.99/month, and includes 350 questions/month, 365 days of history, and stronger analytical capabilities. Paid plans come with a 7-day free trial, and an enterprise plan is also available. Payment is by credit card only, with no support for Pix or installments.
Its strengths are a clear focus on medical use cases, traceable references in answers, integration with PubMed and Anvisa, and the ability to generate study materials, making it useful for medical education and quick verification. The limitations are also obvious: even paid plans still have question caps; Chinese-language support, API availability, and hospital system integration are not specified; and the Anvisa integration is Brazil-focused, offering limited help for Chinese drugs, guidelines, or medical insurance contexts. The platform also clearly warns that AI may produce incorrect or outdated content and cannot replace diagnosis, prescriptions, emergency care, or professional judgment.
Doctor Wise is better suited to medical students, residents, physicians, nurses, and other healthcare professionals as a tool for learning, literature comprehension, and clinical reference support. The text does not provide information on access from mainland China, and credit-card-only payment may also create a barrier. If you need Chinese medical materials, local drugs, or Chinese guidelines, it should be used alongside local medical databases, medication reference tools, DXY-type platforms, or mature evidence-based medicine products such as UpToDate and BMJ Best Practice for cross-checking.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on doctorwise.ai official site.
doctorwise.ai is an Brazil AI Apps provider. TG4G tracks its product information, an overall rating of 8.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach doctorwise.ai directly.